V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016444 | 270009216 | 1.62 | 67 | Palliative (P) | 2014-06-02 | 2014-06-20 | CETUXIMAB + IRINOTECAN + MDG | N | null | 270015293 | CETUXIMAB + IRINOTECAN + MDG |
| 270016445 | 270009220 | 1.71 | 49.3 | null | null | 2016-12-22 | HD EuroNet-PHL-C1 OEPA | N | N | 270015300 | OEPA |
| 270016447 | 270014311 | null | 69.3 | Curative (C) | 2015-05-12 | 2015-06-02 | Cisplatin + Radiotherapy | N | null | 270015303 | CISPLATIN + RT |
| 270016448 | 270009226 | null | 55 | Curative (C) | 2017-10-18 | 2018-08-04 | LEAM | 99 | null | 270015305 | LEAM |
| 270016449 | 270016858 | 1.72 | 92.9 | Disease modification (D) | 2014-05-18 | 2014-07-13 | Rituximab | N | null | 270015309 | RITUXIMAB |
| 270016450 | 270019924 | 1.6 | 73.45 | Palliative (P) | 2016-03-19 | 2016-04-07 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | 270015310 | CETUXIMAB + IRINOTECAN + MDG |
| 270016451 | 270009230 | 1.69 | 70.8 | Disease modification (D) | 2013-05-09 | 2016-04-07 | BEAM | 02 | null | 270015310 | BEAM |
| 270016452 | 270009230 | null | 51.4 | Disease modification (D) | 2016-06-29 | 2016-08-16 | Cisplatin + Radiotherapy | 2 | N | 270015310 | CISPLATIN + RT |
| 270016453 | 270009231 | 1.59 | 59 | Curative (C) | 2016-01-09 | 2016-10-25 | Rituximab | N | N | 270015319 | RITUXIMAB |
| 270016454 | 270009232 | 1.77 | 68.8 | Curative (C) | 2015-02-12 | 2015-02-12 | LEAM | N | N | 270015322 | LEAM |
| 270016455 | 270009232 | 1.52 | 71.2 | null | null | 2014-04-03 | OEPA | N | Y | 270015322 | OEPA |
| 270016456 | 270009233 | 1.73 | 91.2 | Palliative (P) | 2015-04-01 | 2015-04-07 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015328 | CETUXIMAB + IRINOTECAN + MDG |
| 270016457 | 270014316 | 0 | 91.35 | Curative (C) | 2016-08-14 | 2017-07-24 | ESHAP | N | N | 270015329 | ESHAP |
| 270016458 | 270014316 | 1.73 | 106.2 | Curative (C) | 2018-03-23 | 2018-03-23 | OEPA | N | N | 270015329 | OEPA |
| 270016459 | 270016863 | 1.8 | 61.3 | null | 2014-04-20 | 2014-04-21 | HD EuroNet-PHL-C1 OEPA | N | N | 270015333 | OEPA |
| 270016460 | 270009238 | 1.57 | 47 | Curative (C) | 2017-10-11 | 2017-10-11 | Rituximab | null | N | 270015338 | RITUXIMAB |
| 270016461 | 270009241 | null | 75 | Palliative (P) | 2016-07-20 | 2016-07-20 | Rituximab (SUBCUTANEOUS Maintenance) | null | null | 270015339 | RITUXIMAB |
| 270016462 | 270009243 | 1.73 | 60.3 | Disease modification (D) | 2015-02-20 | 2015-04-02 | Rituximab | 99 | null | 270015342 | RITUXIMAB |
| 270016463 | 270014319 | 1.95 | 95 | Palliative (P) | 2013-04-17 | 2013-05-17 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015350 | CETUXIMAB + IRINOTECAN + MDG |
| 270016464 | 270009247 | 1.61 | 59 | Curative (C) | 2013-05-29 | 2013-05-29 | HD EuroNet-PHL-C1 OEPA | N | N | 270015351 | OEPA |
| 270016465 | 270018337 | 1.67 | 66.6 | Curative (C) | 2017-08-22 | 2017-08-25 | OEPA | 02 | null | 270015353 | OEPA |
| 270016466 | 270009248 | 1.6 | 46.6 | Curative (C) | 2016-12-23 | 2017-01-21 | LEAM | N | N | 270015354 | LEAM |
| 270016467 | 270009249 | 0 | 46 | Curative (C) | null | 2017-12-05 | Cisplatin + Radiotherapy | 2 | N | 270015358 | CISPLATIN + RT |
| 270016468 | 270009250 | 1.7 | 67.95 | Curative (C) | 2013-08-15 | 2013-08-22 | BEAM | 99 | N | 270015359 | BEAM |
| 270016469 | 270019181 | 1.67 | 38 | Curative (C) | 2017-07-27 | 2017-08-06 | BEAM | N | N | 270015365 | BEAM |
| 270016470 | 270009252 | 1.68 | null | Curative (C) | 2018-05-13 | 2018-05-13 | ESHAP | 02 | N | 270015366 | ESHAP |
| 270016471 | 270009256 | 1.9 | 87 | null | 2017-04-19 | 2017-04-25 | Rituximab | 99 | N | 270015372 | RITUXIMAB |
| 270016472 | 270009257 | 1.8 | 64.3 | Curative (C) | 2018-03-04 | 2018-06-01 | Rituximab | 02 | null | 270015385 | RITUXIMAB |
| 270016473 | 270014324 | 1.72 | 69.3 | Curative (C) | 2018-07-06 | 2018-07-09 | BEAM | 02 | null | 270015386 | BEAM |
| 270016474 | 270019183 | 0 | 51.5 | Palliative (P) | 2017-09-11 | 2018-02-05 | BEAM | 02 | N | 270015390 | BEAM |
| 270016475 | 270009259 | 1.75 | 85.2 | Curative (C) | 2017-08-07 | 2017-08-08 | OEPA | 02 | null | 270015393 | OEPA |
| 270016476 | 270009261 | 1.76 | 106.2 | Curative (C) | 2017-02-26 | 2017-03-04 | LEAM | N | N | 270015395 | LEAM |
| 270016477 | 270009263 | 1.66 | 73.5 | Curative (C) | 2015-10-13 | 2015-10-20 | Cisplatin 100 + RT(H&N) 1 day | N | N | 270015401 | CISPLATIN + RT |
| 270016478 | 270016872 | 1.7 | 78 | null | 2017-01-02 | 2017-01-07 | OEPA | N | N | 270015404 | OEPA |
| 270016479 | 270009264 | 1.66 | 77.8 | Curative (C) | 2014-10-30 | 2014-10-31 | ESHAP | null | null | 270015405 | ESHAP |
| 270016480 | 270014328 | 1.68 | 89.5 | Adjuvant (A) | 2016-06-17 | 2016-06-17 | OEPA | N | N | 270015405 | OEPA |
| 270016481 | 270009268 | 0 | 87.1 | Curative (C) | 2018-07-27 | 2018-07-28 | HD EuroNet-PHL-C1 OEPA | N | N | 270015420 | OEPA |
| 270016482 | 270009269 | 0 | 64 | Curative (C) | 2014-06-24 | 2014-06-27 | OEPA | null | null | 270015422 | OEPA |
| 270016483 | 270018345 | 1.79 | 50.4 | Curative (C) | 2015-07-17 | 2015-07-17 | LEAM | null | null | 270015429 | LEAM |
| 270016484 | 270009271 | 1.77 | null | Curative (C) | null | 2016-12-26 | Rituximab | 2 | N | 270015438 | RITUXIMAB |
| 270016485 | 270009272 | 1.61 | 59 | null | 2014-11-10 | 2014-11-14 | Rituximab | 99 | null | 270015439 | RITUXIMAB |
| 270016486 | 270009274 | 1.72 | 47.8 | Neo-adjuvant (N) | 2017-05-02 | 2017-07-22 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270015445 | CETUXIMAB + IRINOTECAN + MDG |
| 270016487 | 270014332 | 0 | 48.5 | Curative (C) | 2016-03-23 | 2016-03-23 | CISPLATIN + RT | 2 | N | 270015445 | CISPLATIN + RT |
| 270016488 | 270014332 | 1.56 | 52.3 | Curative (C) | 2016-11-26 | 2016-12-28 | CISPLATIN + RT | 02 | N | 270015445 | CISPLATIN + RT |
| 270016489 | 270014333 | 1.56 | 72 | Palliative (P) | 2017-06-18 | 2017-06-18 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270015458 | CETUXIMAB + IRINOTECAN + MDG |
| 270016490 | 270018347 | 1.66 | 118 | null | null | 2014-09-15 | ESHAP | 2 | N | 270015460 | ESHAP |
| 270016491 | 270009277 | 1.7 | 84 | Disease modification (D) | 2015-09-25 | 2015-09-27 | Rituximab | null | null | 270015462 | RITUXIMAB |
| 270016492 | 270009282 | 1.51 | 84 | Curative (C) | 2018-09-14 | 2018-09-21 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270015465 | CETUXIMAB + IRINOTECAN + MDG |
| 270016493 | 270009284 | 1.72 | 84.45 | Palliative (P) | 2014-10-05 | 2015-05-02 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270015466 | CETUXIMAB + IRINOTECAN + MDG |
| 270016494 | 270009284 | 1.7 | 60 | Curative (C) | 2015-06-23 | 2015-08-02 | LEAM | 99 | N | 270015466 | LEAM |